Alterity Therapeutics Ltd.ASX: ATH

Positive ATH434 Results from Open-Label Phase 2 Trial in MSA

Jul 28, 2025 at 4:20 AM UTC · Issued by Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd has released a press release.

View Attachment